Ajanta Pharma AGM due tomorrow; stock gains

Ajanta Pharma's Annual General Meeting (AGM) is due tomorrow - Wednesday, 17 July. The stock price increased by 1.94% on Tuesday to Rs 2,697.70. This movement reflects a gain compared to the previous day's closing price. Financial Performance Overview Ajanta Pharma has demonstrated consistent financial performance over the past year. The company's revenue and net profit have shown steady growth, indicating a stable and expanding business. Revenue Trends The company's revenue has seen a progressive increase over the last five years. For the year ending March 2021, the revenue stood at Rs 2,889.69 crore, which then increased to Rs 3,340.99 crore in 2022, Rs 3,742.64 crore in 2023, Rs 4,208.71 crore in 2024, and finally reached Rs 4,648.10 crore for the year ending March 2025. This growth trajectory underscores the company's expanding market presence and increasing sales. Net Profit Trends The net profit has also seen a substantial increase over the years. From Rs 653.87 crore in 2021, the net profit increased to Rs 712.68 crore in 2022. There was a dip in 2023 with a net profit of Rs 587.98 crore, but the company recovered strongly, reporting Rs 816.17 crore in 2024 and Rs 920.39 crore for the year ending March 2025. The consistent growth in net profit reflects the company's improved efficiency and profitability. Quarterly Performance Examining the quarterly performance provides further insight into the company's recent financial health. The revenue for the quarter ending March 2024 was Rs 1,054.08 crore, which increased to Rs 1,144.92 crore by June 2024, Rs 1,186.64 crore by September 2024, Rs 1,146.13 crore by December 2024, and Rs 1,170.41 crore for the quarter ending March 2025. Similarly, the net profit has shown positive trends. The net profit for the quarter ending March 2024 was Rs 202.72 crore, which increased to Rs 245.77 crore by June 2024, decreased to Rs 216.48 crore by September 2024, increased to Rs 232.88 crore by December 2024, and landed at Rs 225.26 crore for the quarter ending March 2025. Balance Sheet Highlights The company's balance sheet reflects a stable financial structure. The total equity and liabilities have increased from Rs 3,778 crore in March 2021 to Rs 5,014 crore in March 2025. The assets have also grown proportionally, with total assets matching the total liabilities. Key Ratios Analyzing the financial ratios provides a comprehensive view of the company’s performance. The Basic EPS (Earnings Per Share) has fluctuated over the years, with Rs 75.09 in March 2021, Rs 82.45 in March 2022, Rs 45.89 in March 2023, Rs 64.82 in March 2024, and Rs 73.56 in March 2025. The Return on Networth / Equity (%) has also been robust, with 21.82% in 2021, 21.83% in 2022, 17.35% in 2023, 22.87% in 2024, and 24.28% in 2025. These ratios indicate a strong and efficient operation. The ex-date for the AGM is due tomorrow, which could influence short-term trading dynamics.